FDA Recall D-0048-2023

Pharmacy Plus, Inc. dba Vital Care Compounder · Hattiesburg, MS

Class II Ongoing 1315 days on record

Moderate impact — Class II recall — temporary or medically reversible adverse health consequence possible; remote probability of serious adverse health consequence.

Product

PAPAVERINE/PHENTOLAMINE/PROSTAGLANDIN INJ 150/5/50MCG / VIAL SOLUTION, 10 mL vials, Rx only, Vital Care Compounder, 115 S. 40th Ave., Hattiesburg, MS 39402

Lot / code: Lot: 65594, BUD: 10/16/2022

Quantity: 5 vials

Reason for recall

Lack of Assurance of Sterility: FDA inspection found the recalled products were produced in a manner than cannot guarantee the sterility of the products purported to be sterile.

Recall record

Recall number: D-0048-2023
Classification: Class II
Status: Ongoing
Voluntary or mandated: Voluntary: Firm initiated
Firm notification: Telephone
Distribution: AL, LA, MS, and TN
Recall initiated: 2022-10-07
Classified by FDA Center: 2022-11-02
FDA published: 2022-11-09
Recalling firm: Pharmacy Plus, Inc. dba Vital Care Compounder
Firm location: Hattiesburg, MS

Operational response

Class II recalls indicate possible temporary or reversible health consequences. Remove affected lots from active dispensing. Segregate inventory. Check the firm’s recall notification for guidance on patient outreach.

For the official FDA enforcement record, see FDA's Recall Search.

‹ All recalls